Last reviewed: June 11, 2026

Last updated: June 11, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide works by mimicking glucagon-like peptide-1 (GLP-1), a hormone that signals fullness and slows digestion. When you start injecting semaglutide, your brain receives stronger satiety cues, which reduces hunger and calorie intake naturally. Most patients begin noticing changes within the first two weeks of consistent dosing.

How Semaglutide Injection Works in Your Body

Semaglutide binds to GLP-1 receptors in your brain, pancreas, and digestive tract. This activation slows the rate at which food moves from your stomach into your small intestine, creating a prolonged feeling of fullness. The medication also reduces activity in the brain regions responsible for hunger and food cravings, making it easier to stick to smaller portions without constant willpower.

The drug also improves how your body manages blood sugar, which helps stabilize energy levels throughout the day. When blood sugar remains steady, energy crashes and carb cravings become less intense. This dual mechanism—appetite suppression plus metabolic support—is why semaglutide shows sustained weight loss over months rather than temporary restriction.

PlexusDx compounds semaglutide injections through licensed 503A pharmacies, ensuring pharmaceutical-grade purity and potency. Each dose is prepared specifically for your treatment plan, with no additional fillers or unnecessary ingredients.

Week-by-Week Timeline: What to Expect First

During days one through three, most patients experience minimal change in appetite. Your body is introducing the medication, and GLP-1 receptors are beginning to activate. Some people report mild nausea or a slight change in taste, which typically resolves quickly as your system adjusts. It is normal to feel no dramatic difference during this early window.

By the end of week one through week two, appetite reduction becomes noticeable for many patients. Food that previously seemed appealing may feel less urgent, and portion sizes naturally decrease without active restriction. Energy levels often stabilize as blood sugar regulation improves. Mild gastrointestinal changes like slight constipation or loose stools can occur as your digestive pace adjusts.

Weeks three and four show more pronounced weight loss for most users, typically one to two pounds per week as calorie reduction compounds. Hunger cues continue to soften, and food-related thoughts occupy less mental space. This is when many patients realize the medication is genuinely working, not through discipline but through biological mechanism.

Realistic Weight Loss Results and Timeline

Clinical trials demonstrate that patients on semaglutide lose an average of three to four pounds monthly in the first three months. After six months, average weight loss reaches twelve to sixteen pounds, depending on starting weight and lifestyle factors. By twelve months, many patients achieve twenty to twenty-two percent body weight reduction when combined with modest dietary awareness and movement.

Individual results vary based on genetics, metabolism, concurrent health conditions, and how consistently you use the medication. The Precision Peptide Genetic Test offered by PlexusDx identifies your specific genetic variants in GLP1R, GIPR, FTO, and MC4R pathways, which can predict your likely response pattern to semaglutide. This personalization helps set realistic expectations tailored to your biology.

Weight loss typically continues for nine to twelve months before plateauing, at which point many patients maintain results through ongoing use. Stopping semaglutide can lead to gradual weight regain over months, which is why PlexusDx structures treatment as long-term therapy rather than a short-term fix.

Managing Side Effects and Staying Comfortable

Nausea is the most common side effect, affecting roughly thirty percent of users in the first month. This typically occurs shortly after injection and resolves within hours. Eating smaller, bland meals—toast, crackers, or broth—during the first few hours after dosing can minimize discomfort. Drinking ginger tea or peppermint tea has helped some patients reduce nausea without medication.

Constipation and occasional loose stools reflect changes in digestive speed. Increasing water intake to sixty to eighty ounces daily and adding fiber-rich foods like vegetables, berries, and beans helps regulate bowel function. Light walking or gentle stretching after meals also supports healthy digestion. If constipation becomes severe, consult your healthcare provider about temporary over-the-counter remedies.

Semaglutide injection starts at $149 per month through PlexusDx, with no flat per-compound pricing increases—your dose may need to go up, but your price won't. PlexusDx accepts HSA and FSA funds, and no insurance is required. This flat pricing removes the barrier of escalating costs as your treatment progresses.

Personalizing Your Semaglutide Treatment Plan

PlexusDx offers the Precision Peptide Genetic Test as an add-on after your first month of treatment. This test analyzes your genetic variants across fourteen metabolic pathways and forty-nine peptides, revealing how your body naturally responds to GLP-1 agonists. Key variants like GLP1R rs6923761 and GIPR rs1800437 directly influence medication effectiveness and side effect likelihood.

Understanding your genetic predispositions helps your healthcare provider adjust dosing strategy, predict timeline to results, and identify whether a different compound like tirzepatide might suit you better. Patients with specific FTO or MC4R variants, for example, may benefit from dose optimization or combination therapy approaches. This precision removes guesswork and accelerates your path to sustainable weight loss.

PlexusDx serves all fifty states with no membership fees, no insurance requirement, and direct delivery to your home. Compounding through licensed 503A pharmacies ensures every injection meets pharmaceutical standards for sterility and accuracy. Your treatment remains personalized, affordable, and fully accessible.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How quickly will I lose weight on semaglutide injection?

Most patients notice appetite reduction by week two and measurable weight loss by week four. Average loss reaches three to four pounds monthly in early months, with cumulative results of twelve to sixteen pounds by six months. Individual timelines vary based on metabolism and adherence, which is why PlexusDx offers genetic testing to predict your specific response.

Does semaglutide work immediately or take time to build up?

Semaglutide begins working within days as it activates GLP-1 receptors, but noticeable appetite suppression typically emerges by days seven to ten. Weight loss takes longer to appear because it compounds gradually as your calorie intake decreases. Most clinical changes become obvious by week three or four of consistent dosing.

What is the cost of semaglutide injection at PlexusDx?

PlexusDx offers compounded semaglutide injection starting at $149 per month, with your dose able to increase while your price stays the same. All injections come from licensed 503A compounding pharmacies, and HSA/FSA payments are accepted. No insurance is required, and PlexusDx ships to all fifty states.

What are the most common side effects and how long do they last?

Nausea affects about thirty percent of users in the first month and typically resolves within hours of injection. Constipation or loose stools are common as digestion slows, managed through increased water and fiber intake. Most side effects fade within two to four weeks as your body adapts to the medication.

Can genetic testing predict how well semaglutide will work for me?

Yes. PlexusDx's Precision Peptide Genetic Test analyzes variants in GLP1R, GIPR, FTO, and MC4R pathways across fourteen total metabolic pathways. These genetic insights predict your likely response to semaglutide, potential side effect patterns, and whether combination therapy might suit you better. Testing costs $99 as an add-on after your first month.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves